Pulse Biosciences, Inc. (PLSE)

Market Cap	304.50M
Revenue (ttm)	256,000
Net Income (ttm)	-51.03M
Shares Out	47.62M
EPS (ttm)	-1.41
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,497
Open	6.30
Previous Close	6.40
Day's Range	6.20 - 6.44
52-Week Range	1.18 - 9.69
Beta	1.14
Analysts	Hold
Price Target	n/a
Earnings Date	May 11, 2023

About PLSE

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 201...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 18, 2016
• Employees: 61
• Stock Exchange: NASDAQ
• Ticker Symbol: PLSE

Financial Performance

In 2022, PLSE's revenue was $700,000, a decrease of -50.63% compared to the previous year's $1.42 million. Losses were -$58.51 million, -8.10% less than in 2021.